Polynucleotide treatment is a **regenerative injectable therapy** made from purified DNA fragments, usually sourced from salmon or trout. Sounds odd at first, I know. The idea is that these DNA chains act like biological messengers. Once injected into the skin, they bind water, reduce inflammation, and signal fibroblasts to repair tissue and improve skin quality over time. Its not filler. It doesnt push or lift. Its more like giving the skin better instructions and raw materials so it can heal itself. Brands youll hear a lot in the UK are **Plinest**, **PhilArt**, and **Nucleofill**. ([aestheticsjournal.com](https://aestheticsjournal.com/feature/polynucleotides-the-regenerative-injectable))
Our dataset currently has 2 clinic(s), with approximately 35 reviews and an average rating of 5.
Medical Infrastructure:
- Primary care GP practices within Carshalton
- Secondary care access via Epsom and St Helier University Hospitals NHS Trust
- Strong private healthcare presence across Greater London.
Local Aethetics Market:
- Established and trend-responsive
- Regenerative injectables (polynucleotides) and RF microneedling indicate mid-to-advanced adoption.
- Avoid alcohol and blood-thinning meds 2448 hours before if advised.
- Arrive with clean skin, no makeup on the treatment area.
- Plan a low-key day afterward in case of swelling.
- Have realistic expectations. This is a slow burn treatment.
Most protocols suggest **23 sessions spaced 24 weeks apart**.
Generally well tolerated with a low complication rate.Temporary swelling, redness, or small lumps at injection sites are common.Products are purified and biocompatible. ([aestheticsjournal.com](https://aestheticsjournal.com/feature/polynucleotides-the-regenerative-injectable))
Most people describe it as mild to moderate discomfort. Numbing cream is usually used, especially for sensitive areas like under eyes.
- Medical qualification with injectable training.
- Specific education in regenerative injectables.
- Strong anatomical knowledge, especially for eye area treatments.
- Professional indemnity insurance.
There are no dedicated NICE guidelines specifically for polynucleotides. MHRA regulates the products used, and practitioners are expected to follow general injectable and aesthetic medicine safety standards. Clinical use is guided by emerging evidence and professional consensus rather than formal national protocols.
Local regulatory authority:
- Care Quality Commission (CQC) for regulated medical activities in England
- Practitioner-level oversight via General Medical Council (GMC) and Nursing and Midwifery Council (NMC) where applicable.
Private insurance usage locally:
- Elective cosmetic procedures typically self-funded
- Not covered by standard private medical insurance.
Cosmetic finance availability:
- Common across Greater London via third-party providers (e.g., aesthetic finance platforms)
- Availability likely through London-based partnerships.
- Medical qualification with injectable training.
- Specific education in regenerative injectables.
- Strong anatomical knowledge, especially for eye area treatments.
- Professional indemnity insurance.
- A medically qualified injector who understands facial anatomy properly.
- Someone who explains that this is about skin quality, not volume.
- Clear consent process and discussion of alternatives.
- Experience treating delicate areas like the under eyes. ([harleyacademy.com](https://www.harleyacademy.com/aesthetic-courses/polynucleotides/))
Current average rating citywide: 5
